Christine J. Saoud

Array ( [id] => 5404487 [patent_doc_number] => 20090239801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Modified Fusion Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/389022 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5298 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239801.pdf [firstpage_image] =>[orig_patent_app_number] => 12389022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7503510 [patent_doc_number] => 08034772 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Inhibitor of vascular endothelial cell growth factor' [patent_app_type] => utility [patent_app_number] => 12/322800 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 9733 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034772.pdf [firstpage_image] =>[orig_patent_app_number] => 12322800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8908972 [patent_doc_number] => 08481031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-09 [patent_title] => 'Methods and compositions using Klotho-FGF fusion polypeptides' [patent_app_type] => utility [patent_app_number] => 12/360970 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 23504 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12360970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959047 [patent_doc_number] => 20110183434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'DIAGNOSTIC METHODS AND KITS USING FIBROBLAST GROWTH FACTOR-23' [patent_app_type] => utility [patent_app_number] => 12/812994 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32285 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183434.pdf [firstpage_image] =>[orig_patent_app_number] => 12812994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5539172 [patent_doc_number] => 20090220977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses' [patent_app_type] => utility [patent_app_number] => 12/319689 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 536 [patent_figures_cnt] => 536 [patent_no_of_words] => 216042 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12319689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8152102 [patent_doc_number] => 08168590 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Use of proteolysis resistant active VEGF' [patent_app_type] => utility [patent_app_number] => 12/349531 [patent_app_country] => US [patent_app_date] => 2009-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4895 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168590.pdf [firstpage_image] =>[orig_patent_app_number] => 12349531 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5265505 [patent_doc_number] => 20090118190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'MUTEINS OF FIBROBLAST GROWTH FACTOR 21' [patent_app_type] => utility [patent_app_number] => 12/349119 [patent_app_country] => US [patent_app_date] => 2009-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8866 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20090118190.pdf [firstpage_image] =>[orig_patent_app_number] => 12349119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434965 [patent_doc_number] => 20090169551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR ACTIVATING OR INHIBITING VEGF-D AND VEGF-C' [patent_app_type] => utility [patent_app_number] => 12/331104 [patent_app_country] => US [patent_app_date] => 2008-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9145 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169551.pdf [firstpage_image] =>[orig_patent_app_number] => 12331104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4594972 [patent_doc_number] => 07981419 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Method for treating hypophosphatemic bone diseases using FGF-23 antibody' [patent_app_type] => utility [patent_app_number] => 12/325551 [patent_app_country] => US [patent_app_date] => 2008-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 39 [patent_no_of_words] => 41857 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981419.pdf [firstpage_image] =>[orig_patent_app_number] => 12325551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266384 [patent_doc_number] => 20100298212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Modified Insulin Polypeptides and Their Uses' [patent_app_type] => utility [patent_app_number] => 12/740619 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 96895 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298212.pdf [firstpage_image] =>[orig_patent_app_number] => 12740619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284928 [patent_doc_number] => 20090098603 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'POLYPEPTIDES SHARING SEQUENCE IDENTITY WITH A FIBROBLAST GROWTH FACTOR POLYPEPTIDE AND NUCLEIC ACIDS ENCODING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/273334 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38332 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098603.pdf [firstpage_image] =>[orig_patent_app_number] => 12273334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422430 [patent_doc_number] => 20090148885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Fibroblast Growth Factor-Like Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/270561 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 27720 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148885.pdf [firstpage_image] =>[orig_patent_app_number] => 12270561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6252000 [patent_doc_number] => 20100028349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'Fibroblast Growth Factor-Like Polypeptides' [patent_app_type] => utility [patent_app_number] => 12/270501 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30217 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028349.pdf [firstpage_image] =>[orig_patent_app_number] => 12270501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7687584 [patent_doc_number] => 20090176707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'HUMAN SIGNAL PEPTIDE-CONTAINING PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/270629 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44288 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176707.pdf [firstpage_image] =>[orig_patent_app_number] => 12270629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4458881 [patent_doc_number] => 07879323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Antibodies to fibroblast growth factor-like polypeptides' [patent_app_type] => utility [patent_app_number] => 12/270449 [patent_app_country] => US [patent_app_date] => 2008-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 30216 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879323.pdf [firstpage_image] =>[orig_patent_app_number] => 12270449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436163 [patent_doc_number] => 20090170750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Single-Chain Insulin' [patent_app_type] => utility [patent_app_number] => 12/251901 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15900 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170750.pdf [firstpage_image] =>[orig_patent_app_number] => 12251901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446944 [patent_doc_number] => 20090048170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'TARGET FOR ANTI-ANGIOGENESIS THERAPY' [patent_app_type] => utility [patent_app_number] => 12/240656 [patent_app_country] => US [patent_app_date] => 2008-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22878 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048170.pdf [firstpage_image] =>[orig_patent_app_number] => 12240656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083627 [patent_doc_number] => 20110144024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'PREVENTION AND TREATMENT OF RADIATION INJURY' [patent_app_type] => utility [patent_app_number] => 13/054756 [patent_app_country] => US [patent_app_date] => 2008-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8315 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144024.pdf [firstpage_image] =>[orig_patent_app_number] => 13054756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458044 [patent_doc_number] => 08293711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Use of natriuretic peptides for treating angioedema syndromes' [patent_app_type] => utility [patent_app_number] => 12/733609 [patent_app_country] => US [patent_app_date] => 2008-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2711 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12733609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410155 [patent_doc_number] => 08273552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Modified growth hormone polypeptides' [patent_app_type] => utility [patent_app_number] => 12/678282 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 32 [patent_no_of_words] => 5956 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12678282 [rel_patent_id] =>[rel_patent_doc_number] =>)